Table 3.

Number of all-cause deaths and HR for all-cause death comparing patients with SLE to those without at 4 timepoints of the year-long followup.

Time Since Stroke OnsetAll-cause Death*HR (95% CI)
SLENon-SLEModel 1Model 2
Ischemic stroken = 363n = 1436
1 mo25 (7)115 (8)1.10 (0.71–1.72)0.85 (0.53–1.37)
3 mos40 (11)152 (11)1.43 (1.00–2.05)1.11 (0.75–1.63)
6 mos50 (14)178 (12)1.60 (1.16–2.22)1.21 (0.85–1.71)
12 mos68 (19)215 (15)1.85 (1.39–2.45)1.41 (1.04–1.91)
  Age < 65 yrs12/149 (8)12/304 (4)2.29 (0.99–5.30)1.92 (0.78–4.74)
  Age ≥ 65 yrs56/202 (26)203/1132 (18)1.77 (1.31–2.40)1.35 (0.97–1.87)
Hemorrhagic stroken = 60n = 216
1 mo18 (30)41 (19)2.37 (1.32–4.24)1.73 (0.87–3.42)
3 mos24 (40)45 (21)2.67 (1.57–4.54)2.01 (1.08–3.75)
6 mos25 (42)49 (23)2.53 (1.50–4.26)1.94 (1.05–3.57)
12 mos25 (42)56 (26)2.30 (1.38–3.82)1.74 (0.95–3.17)
  Age < 65 yrs11/29 (38)6/47 (13)5.79 (1.60–20.86)6.00 (1.23–29.10)
  Age ≥ 65 yrs14/31 (45)50/169 (30)1.84 (0.98–3.43)1.67 (0.81–3.45)
  • * Data are n (%), or n/total in category (%) for age stratifications.

  • Adjusted for age at stroke onset, sex, region of residence, country of birth, education, and calendar period (stroke onset during or after 2006).

  • Further adjusted for history of congestive heart disease, hypertension, diabetes, atrial fibrillation, chronic kidney disease, and infection frailty at stroke onset. SLE: systemic lupus erythematosus.